Back to Browse Journals » International Journal of General Medicine » Volume 6

Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient

Authors Yates SW

Published Date March 2013 Volume 2013:6 Pages 167—180

DOI http://dx.doi.org/10.2147/IJGM.S39379

Received 20 October 2012, Accepted 3 December 2012, Published 21 March 2013

Scott W Yates

Center for Executive Medicine, Plano, TX, USA

Abstract: Atrial fibrillation (AF) is a common arrhythmia that is associated with an increased risk of stroke, particularly in the elderly. Traditionally, a vitamin K antagonist such as warfarin is prescribed for stroke prevention. Warfarin is effective at lowering stroke risk but has several limitations due to food restrictions, drug interactions, and a narrow therapeutic window. Various novel oral anticoagulants (NOACs) are available or under development to provide alternative treatment options. This article reviews the efficacy and safety of three NOACs (dabigatran etexilate, rivaroxaban, and apixaban) in addition to warfarin and aspirin, for prevention of stroke in patients with AF, focusing on the elderly population. Results of clinical trials demonstrate that the efficacy of NOACs for stroke prevention in patients with AF is as good as or better than that of warfarin. The NOACs are also associated with an equivalent or lower risk of bleeding. Regardless of the medication chosen, older patients with AF must be treated cautiously due to an increased risk of stroke and bleeding, as well as potential challenges related to drug interactions and monitoring requirements. NOACs may be suitable alternatives to warfarin for stroke prevention in older patients due to several advantages, including a faster onset of action, few drug or food interactions, and no requirement for regular monitoring. However, dose adjustments may be required for certain patients, such as those with severe renal impairment or in the setting of drug interactions.

Keywords: aspirin, warfarin, dabigatran etexilate, rivaroxaban, apixaban

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Effectiveness of exercise on cognitive impairment and Alzheimer's disease

Balsamo S, Willardson JM, Santana FS, Prestes J, Balsamo DC, Nascimento DC, dos Santos-Neto L, Nobrega OT

International Journal of General Medicine 2013, 6:387-391

Published Date: 24 May 2013

Telemonitoring should have a central role in future health care

Yarrow-Jenkins A, Lemon TI

International Journal of General Medicine 2013, 6:357-359

Published Date: 13 May 2013

Impact of admission blood glucose level on outcomes in community-acquired pneumonia in older adults

Bhattacharya RK, Mahnken JD, Rigler SK

International Journal of General Medicine 2013, 6:341-344

Published Date: 6 May 2013

Prevalence of hypertension in the rural adult population of Osun State, southwestern Nigeria

Asekun-Olarinmoye EO, Akinwusi PO, Adebimpe WO, Isawumi MA, Hassan MB, Olowe OA, Makanjuola OB, Alebiosu CO, Adewole TA

International Journal of General Medicine 2013, 6:317-322

Published Date: 26 April 2013

Analysis of participation and performance in athletes by age group in ultramarathons of more than 200 km in length

Zingg MA, Knechtle B, Rüst CA, Rosemann T, Lepers R

International Journal of General Medicine 2013, 6:209-220

Published Date: 9 April 2013

Effects of home telemonitoring on transitions between frailty states and death for older adults: a randomized controlled trial

Upatising B, Hanson GJ, Kim YL, Cha SS, Yih Y, Takahashi PY

International Journal of General Medicine 2013, 6:145-151

Published Date: 14 March 2013

Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study

Fouad A, Sabry D, Ahmed R, Kamal M, Abd Allah S, Marzouk S, Amin M, Abd Al Aziz R, El Badri A, Khattab H, Helmy D

International Journal of General Medicine 2013, 6:127-134

Published Date: 12 March 2013

Prevalence of symptoms and risk of sleep apnea in Dubai, UAE

Mahboub B, Afzal S, Alhariri H, Alzaabi A, Vats M, Soans A

International Journal of General Medicine 2013, 6:109-114

Published Date: 6 March 2013